NLRP3 and liver dysplastic nodule: In addition to blood glucose control, some agents with anti-inflammatory and antioxidant properties, such as cytokine inhibitor, ROS inhibitor, and NLRP3 inflammasome inhibitor, can also be selected to treat DN.